Catestatin suppresses melanoma progression and drug resistance through multitargeted modulation of signaling pathways
Satadeepa Kal(University of California San Diego), Sushil K. Mahata(University of California San Diego)
Cited by 0
Related Papers
Catecholamine Release–Inhibitory Peptide Catestatin (Chromogranin A <sub>352–372</sub> )
|Circulation|2007|113
Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk
|Journal of Clinical Investigation|2007|90
Proteolytic Cleavage of Chromogranin A (CgA) by Plasmin
|Journal of Biological Chemistry|2001|79
Formation of the Catecholamine Release-inhibitory Peptide Catestatin from Chromogranin A
|Journal of Biological Chemistry|2000|75